BASKING RIDGE, NJ, June 7, 2010—Life science services company i3 announced today that Anne Tomalin, head of i3’s strategic regulatory services group, was honored with the 2010 Canadian Society for Pharmaceutical Sciences (CSPS) Leadership Award at a gala reception during the CSPS 13th Annual Symposium, June 4, 2010, in Richmond, BC. This annual award is bestowed upon a scientist who has demonstrated leadership in advancing the cause of pharmaceutical research and development in Canada.
Since founding CanReg in 1996, Anne grew the business to include more than 100 in-house consultants and staff before i3 acquired the company in 2009. Prior to starting CanReg, Anne worked for 20 years at Searle Canada and also spent time at Hoffman La-Roche and Wyeth.
“We can think of no more deserving person to receive this prestigious award than Anne,” said Tracy Tsuetaki, president, i3 Research. “In CanReg, she created a global leader with unmatched experience in navigating the regulatory process to bring important products to market, and she and her team have been an asset at i3 in enhancing the high-quality work that we do.”
CSPS is the premier organization for bringing together pharmaceutical scientists in Canada. In the notification of the award, CSPS President Laszlo Endrenyi, PhD, D. Sc., acknowledged Anne’s “outstanding leadership as the founder of CanReg, the most successful regulatory consulting firm in Canada and beyond.”
About i3
i3 takes a 360-degree view of healthcare to help its global pharmaceutical, biotechnology, and medical device customers bring safe and effective products to market quickly and help demonstrate their value, leading to increased ROI and better patient care. i3’s integrated businesses combine a deep understanding of data and methodologies; therapeutic, scientific, and functional proficiency; and the expertise to help design research that demonstrates a product’s value, and helps achieve market access and assure reimbursement. More information about i3 can be obtained at www.i3global.com.
